Cecors Inc Stock Net Income
| CEOS Stock | USD 0 0.0003 13.04% |
As of the 1st of March, CeCors owns the coefficient of variation of 1564.3, and Market Risk Adjusted Performance of 71.09. CeCors Inc technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CeCors Inc standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if CeCors Inc is priced favorably, providing market reflects its prevailing price of 0.0026 per share. As CeCors Inc appears to be a penny stock we also recommend to validate its total risk alpha numbers.
CeCors' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing CeCors' valuation are provided below:CeCors Inc does not now have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. CeCors |
CeCors 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CeCors' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CeCors.
| 12/01/2025 |
| 03/01/2026 |
If you would invest 0.00 in CeCors on December 1, 2025 and sell it all today you would earn a total of 0.00 from holding CeCors Inc or generate 0.0% return on investment in CeCors over 90 days. Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingr... More
CeCors Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CeCors' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CeCors Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 14.74 | |||
| Information Ratio | 0.0571 | |||
| Maximum Drawdown | 82.91 | |||
| Value At Risk | (17.14) | |||
| Potential Upside | 26.09 |
CeCors Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CeCors' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CeCors' standard deviation. In reality, there are many statistical measures that can use CeCors historical prices to predict the future CeCors' volatility.| Risk Adjusted Performance | 0.0584 | |||
| Jensen Alpha | 0.8307 | |||
| Total Risk Alpha | (0.54) | |||
| Sortino Ratio | 0.051 | |||
| Treynor Ratio | 71.08 |
CeCors March 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0584 | |||
| Market Risk Adjusted Performance | 71.09 | |||
| Mean Deviation | 8.48 | |||
| Semi Deviation | 10.01 | |||
| Downside Deviation | 14.74 | |||
| Coefficient Of Variation | 1564.3 | |||
| Standard Deviation | 13.17 | |||
| Variance | 173.32 | |||
| Information Ratio | 0.0571 | |||
| Jensen Alpha | 0.8307 | |||
| Total Risk Alpha | (0.54) | |||
| Sortino Ratio | 0.051 | |||
| Treynor Ratio | 71.08 | |||
| Maximum Drawdown | 82.91 | |||
| Value At Risk | (17.14) | |||
| Potential Upside | 26.09 | |||
| Downside Variance | 217.35 | |||
| Semi Variance | 100.23 | |||
| Expected Short fall | (13.56) | |||
| Skewness | 0.5275 | |||
| Kurtosis | 2.46 |
CeCors Inc Backtested Returns
CeCors appears to be out of control, given 3 months investment horizon. CeCors Inc retains Efficiency (Sharpe Ratio) of 0.062, which signifies that the company had a 0.062 % return per unit of risk over the last 3 months. By reviewing CeCors' technical indicators, you can evaluate if the expected return of 0.65% is justified by implied risk. Please makes use of CeCors' coefficient of variation of 1564.3, and Market Risk Adjusted Performance of 71.09 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, CeCors holds a performance score of 4. The firm owns a Beta (Systematic Risk) of 0.0117, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CeCors' returns are expected to increase less than the market. However, during the bear market, the loss of holding CeCors is expected to be smaller as well. Please check CeCors' information ratio and the relationship between the maximum drawdown and day median price , to make a quick decision on whether CeCors' current price history will revert.
Auto-correlation | -0.29 |
Weak reverse predictability
CeCors Inc has weak reverse predictability. Overlapping area represents the amount of predictability between CeCors time series from 1st of December 2025 to 15th of January 2026 and 15th of January 2026 to 1st of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CeCors Inc price movement. The serial correlation of -0.29 indicates that nearly 29.0% of current CeCors price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.29 | |
| Spearman Rank Test | -0.44 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, CeCors Inc reported net income of (9.3 Million). This is 102.73% lower than that of the Healthcare sector and 109.34% lower than that of the Medical Instruments & Supplies industry. The net income for all United States stocks is 101.63% higher than that of the company.
CeCors Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CeCors' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CeCors could also be used in its relative valuation, which is a method of valuing CeCors by comparing valuation metrics of similar companies.CeCors is currently under evaluation in net income category among its peers.
CeCors Fundamentals
| Return On Equity | -7.26 | |||
| Return On Asset | -1.8 | |||
| Current Valuation | 87.7 K | |||
| Price To Earning | (0.05) X | |||
| EBITDA | (3.72 M) | |||
| Net Income | (9.3 M) | |||
| Cash And Equivalents | 57.42 K | |||
| Total Debt | 956.88 K | |||
| Current Ratio | 0.33 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (6.88 M) | |||
| Earnings Per Share | (0.41) X | |||
| Beta | 0.11 | |||
| Market Capitalization | 14.15 K | |||
| Total Asset | 2.26 M | |||
| Retained Earnings | (33.91 M) | |||
| Working Capital | (229 K) | |||
| Current Asset | 114 K | |||
| Current Liabilities | 343 K | |||
| Z Score | -24.3 | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 2.26 M |
About CeCors Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CeCors Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CeCors using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CeCors Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CeCors Pink Sheet Analysis
When running CeCors' price analysis, check to measure CeCors' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CeCors is operating at the current time. Most of CeCors' value examination focuses on studying past and present price action to predict the probability of CeCors' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CeCors' price. Additionally, you may evaluate how the addition of CeCors to your portfolios can decrease your overall portfolio volatility.